首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Recent applications of hydantoin and thiohydantoin in medicinal chemistry
【24h】

Recent applications of hydantoin and thiohydantoin in medicinal chemistry

机译:杜兰苯胺和硫代苯胺在药用化学中的最新应用

获取原文
获取原文并翻译 | 示例
           

摘要

Hydantoin, imidazolidine-2,4-dione, is a non-aromatic five-membered heterocycle, which is considered a valuable, privileged scaffold in medicinal chemistry. The importance of the hydantoin scaffold in drug discovery has been reinforced by several medicines in clinical use, such as phenytoin, nitrofurantoin, and enzalutamide. Hydantoin has five potential substituent sites, including two hydrogen bond acceptors and two hydrogen bond donors. Two additional attractive features of hydantoin scaffolds are their synthetic feasibility for core scaffolds via established cyclization reactions and their ease of accepting various substituents. Because of these characteristics, many hydantoin derivatives with different substituents have been designed and synthesized and exhibit a broad spectrum of biological and pharmacological activities against, for example, cancers, microbial infections, metabolic diseases, and epilepsy. In this review, recent contributions of hydantoin, thiohydantoin, and selenohydantoin scaffolds to medicinal chemistry are described; some major compounds are presented to emphasize their importance, and their structure-activity relationships (SARs) are briefly addressed. Major discussions are devoted to the structural features or novelty of each scaffold and its SAR. The publications in this review encompass those from 2012 to 2018. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:杜娟素,咪唑烷-2,4-二酮,是一种非芳香族五元杂环,其被认为是药用化学中有价值的,特殊的支架。在临床用途的几种药物中,淡黄素支架在药物发现中的重要性,如临床用途,如苯妥辛,呋喃脲和依齐甲酰胺。杜娟林有五个潜在的取代基位点,包括两个氢键受体和两个氢键供体。杜兰林支架的两种额外有吸引力的特征是它们通过建立的环化反应和易于接受各种取代基的核心支架的合成可行性。由于这些特征,许多具有不同取代基的乙素衍生物已经设计和合成并表现出对例如癌症,微生物感染,代谢疾病和癫痫的广谱生物和药理活动。在本次综述中,描述了最近的淡素,硫代硫脲和硒脱发素支架到药用化学的贡献;提出了一些主要化合物以强调他们的重要性,并简要介绍其结构 - 活动关系(SARS)。主要讨论致力于每个脚手架及其特征的结构特征或新颖性。本综述中的出版物包括2012年至2018年的出版物。(c)2019年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号